Epigenetics in the pathogenesis of diabetic nephropathy

被引：94

作者：

Li, Xue ^{[1
]}

Lu, Lihong ^{[1
]}

Hou, Wenting ^{[1
]}

Huang, Ting ^{[1
]}

Chen, Xiangyuan ^{[1
]}

Qi, Jie ^{[2
]}

Zhao, Yanjun ^{[3
]}

Zhu, Minmin ^{[1
,2
]}

机构：

[1] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Anesthesiol,Dept Oncol, Shanghai 200032, Peoples R China

[2] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Anesthesiol, Sch Med, Shanghai 200080, Peoples R China

[3] Fudan Univ, Eye & ENT Hosp, Dept Anesthesiol, Shanghai 200031, Peoples R China

来源：

ACTA BIOCHIMICA ET BIOPHYSICA SINICA | 2022年 / 54卷 / 02期

基金：

美国国家科学基金会;

关键词：

diabetes; diabetic nephropathy; epigenetics; metabolic memory; LONG NONCODING RNA; GLYCATION END-PRODUCTS; HISTONE DEACETYLASE; GENE-EXPRESSION; HYPERGLYCEMIC MEMORY; METABOLIC-REGULATION; INSULIN-RESISTANCE; OXIDATIVE STRESS; PODOCYTE INJURY; DNA METHYLATION;

D O I：

10.3724/abbs.2021016

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Diabetic nephropathy (DN), which is a common microvascular complication with a high incidence in diabetic patients, greatly increases the mortality of patients. With further study on DN, it is found that epigenetics plays a crucial role in the pathophysiological process of DN. Epigenetics has an important impact on the development of DN through a variety of mechanisms, and promotes the generation and maintenance of metabolic memory, thus ultimately leading to a poor prognosis. In this review we discuss the methylation of DNA, modification of histone, and regulation of non-coding RNA involved in the progress of cell dysfunction, inflammation and fibrosis in the kidney, which ultimately lead to the deterioration of DN.

引用

页码：163 / 172

页数：10

共 50 条

[41] The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy
Tang, Jian
Yao, Deyi
Yan, Haiying
Chen, Xing
Wang, Linjia
Zhan, Huakui
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2019, 2019
[42] Diabetic Nephropathy: New insights into Pathogenesis
Alpers, C. E.
JOURNAL OF PATHOLOGY, 2018, 246 : S7 - S7
[43] ALTERED HEMORHEOLOGY IN THE PATHOGENESIS OF DIABETIC NEPHROPATHY
SHAND, BI
BAILEY, RR
GRAHAM, PJ
LYNN, KL
ROBSON, RA
KIDNEY INTERNATIONAL, 1994, 45 (04) : 1273 - 1273
[44] The RAAS in the pathogenesis and treatment of diabetic nephropathy
Ruggenenti, Piero
Cravedi, Paolo
Remuzzi, Giuseppe
NATURE REVIEWS NEPHROLOGY, 2010, 6 (06) : 319 - 330
[45] Recent Progress in Genetics and Epigenetics Research on Diabetic Nephropathy in Malaysia
Abu Seman, Norhashimah
Othman, Siti Haslina
JOURNAL OF DIABETES RESEARCH, 2023, 2023
[46] Epigenetics and endoplasmic reticulum in podocytopathy during diabetic nephropathy progression
Wang, Xiaokang
Zhao, Jingqian
Li, Yuanqing
Rao, Jiaoyu
Xu, Gengrui
FRONTIERS IN IMMUNOLOGY, 2022, 13
[47] The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy
Doi, Toshio
Mima, Akira
Matsubara, Takeshi
Tominaga, Tatsuya
Arai, Hidenori
Abe, Hideharu
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 : S21 - S24
[48] Role of mesangial expansion in the pathogenesis of diabetic nephropathy
Dalla Vestra, M
Saller, A
Mauer, M
Fioretto, P
JOURNAL OF NEPHROLOGY, 2001, 14 : S51 - S57
[49] Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, Nur
BIOMED RESEARCH INTERNATIONAL, 2021, 2021
[50] HEPARAN-SULFATE IN THE PATHOGENESIS OF DIABETIC NEPHROPATHY
KOFOEDENEVOLDSEN, A
DIABETES-METABOLISM REVIEWS, 1995, 11 (02): : 137 - 160

← 1 2 3 4 5 →